Literature DB >> 32072476

Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions.

Bagher Larijani1, Najmeh Foroughi Heravani2, Sepideh Alavi-Moghadam2, Parisa Goodarzi3, Mostafa Rezaei-Tavirani4, Moloud Payab5, Mahdi Gholami6, Farideh Razi7, Babak Arjmand8,9.   

Abstract

Autism spectrum disorders as a group of pediatric neurodevelopmental diseases is a crucial part of the worldwide disabilities which have influence in communication skills, social interactions, and ability to understand the concepts. The precise pathophysiology of autism spectrum disorders due to the abundance of involved mechanisms is unknown. Some of these involved mechanisms are related to genetic factors, chronic neuro inflammation, mitochondrial dysfunction, oxidative stress, immune dysregulation, hormonal imbalance, and environmental factors. Current main treatments for autisms are behavioral, nutritional and medical therapies, however there is not definitive treatment approach. Therein, more novel therapies are still required to improve the symptoms. Several preclinical and clinical evidence were shown that stem cell therapy is a potential treatment option for autism spectrum disorders individuals. Considering the significant factors which can affect the outcome of stem cell therapeutic effects including stem cell types, route and dosage of administration, and mechanism of activity along with selecting best animal models can be very important in performing clinical trials.

Entities:  

Keywords:  Autism spectrum disorders; Neuro inflammation; Neurological disorders; Regenerative medicine; Stem cell therapy

Year:  2020        PMID: 32072476     DOI: 10.1007/5584_2020_491

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  An Overview of Zebrafish Modeling Methods in Drug Discovery and Development.

Authors:  Bagher Larijani; Shayesteh Kokabi Hamidpour; Akram Tayanloo-Beik; Ainaz Shahbazbadr; Hanieh Yavari; Nazli Namazi; Mahmood Biglar; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 2.  Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Moloud Payab; Forough Azam Sayahpour; Hamid Reza Aghayan; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Bagher Larijani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2020-06-25       Impact factor: 1.522

Review 3.  Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives.

Authors:  Mina Abedi; Sepideh Alavi-Moghadam; Moloud Payab; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Cell Regen       Date:  2020-12-01

Review 4.  Zebrafish Modeling of Autism Spectrum Disorders, Current Status and Future Prospective.

Authors:  Akram Tayanloo-Beik; Shayesteh Kokabi Hamidpour; Mina Abedi; Hamide Shojaei; Mostafa Rezaei Tavirani; Nazli Namazi; Bagher Larijani; Babak Arjmand
Journal:  Front Psychiatry       Date:  2022-07-14       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.